3-Bromo-6-methoxy-2-methyl-5-nitropyridine, 98%, 250mg

Ethyl thiosalicylate, 250mg

1-Amino-3-phenylcyclobutane-1-carboxylic acid, 95%, 500mg

2-Hydroxy-2-(4-hydroxy-3-methoxyphenyl)acetic acid, 95.0%, 1g

1-piperidin-4-ylpent-4-en-1-one hydrochloride, 250mg

3,3'-Bithiophene, 95.0%, 1g

(2-Benzylthiazol-4-yl)methanol, 250mg

N-BROMOACETAMIDE, 95.0%, 5g

Idrossitoluene butilato, minimo 99,7%, per sintesi, 250 g, confezione in plastica.

(1R,5R)-3-methyl-3,6-diazabicyclo[3.2.0]heptane; bis(trifluoroacetic acid), 95.0%, 1g

3-(5-Chloromethyl-[1,2,4]oxadiazol-3-yl)-aniline, 97.0%, 5g

1-Methyl-3-[6-(methylsulfinyl)hexyl]imidazolium p-Toluenesulfonate>97.0%(HPLC)(N)5g

4-Methyl-2-(phenylmethoxy)benzoic acid, 98%, 1g